Literature DB >> 18685386

Assessment and diagnosis of neuropathic pain.

Ralf Baron1, Thomas R Tölle.   

Abstract

PURPOSE OF REVIEW: Classification of neuropathic pain has been based on disease entities, anatomical localization or histological observations. There is now recognition from clinical investigations that neuropathic pain is not a monolithic entity, but instead presents as a composite of pain and other sensory symptoms. RECENT
FINDINGS: Attempts are underway to supplement the traditional classification with a classification that links pain and sensory symptoms with neurobiological mechanisms. This mechanism or symptom-based classification takes negative and positive sensory symptoms into account. By using a battery of standardized quantitative sensory tests the characteristic profile of sensory symptoms can be elucidated in each patient with a bedside assessment. These procedures can be fostered by apparative neurophysiological analysis, imaging techniques and biopsies. Moreover, in questionnaires verbal descriptors can depict the quality and intensity of the individual pain. They have proven to be sensible screening tools for neuropathic pain components.
SUMMARY: Application of quantitative sensory testing and questionnaires can aid in more versatile descriptions of neuropathic pain symptoms. If it were possible to characterize the concert of the distinct mechanisms and symptoms that operate in one individual patient, an optimal polypharmacotherapy that addresses the specific combinations of mechanisms may be established for each patient.

Entities:  

Mesh:

Year:  2008        PMID: 18685386     DOI: 10.1097/SPC.0b013e3282f57da5

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  15 in total

Review 1.  Phenotyping and genotyping neuropathic pain.

Authors:  Inna Belfer; Feng Dai
Journal:  Curr Pain Headache Rep       Date:  2010-06

2.  Predicting postoperative pain based on preoperative pain perception: are we doing better than the weatherman?

Authors:  Srinivasa N Raja; Troels S Jensen
Journal:  Anesthesiology       Date:  2010-06       Impact factor: 7.892

Review 3.  [Pain - a neglected neurological issue].

Authors:  F Birklein; R Baron; C Gaul; C Maihöfner; O Rommel; A Straube; T Tölle; G Wasner
Journal:  Nervenarzt       Date:  2016-06       Impact factor: 1.214

4.  Awareness of Fabry disease among rheumatologists--current status and perspectives.

Authors:  Rolando Cimaz; Severine Guillaume; Max J Hilz; Gerd Horneff; Bernhard Manger; J Carter Thorne; Anette Torvin Møller; Nico M Wulffraat; Johannes Roth
Journal:  Clin Rheumatol       Date:  2011-04       Impact factor: 2.980

5.  [Pain perception of adolescents with chronic functional pain : adaptation and psychometric validation of the Pain Perception Scale (SES) by Geissner].

Authors:  J Wager; A-L Tietze; H Denecke; S Schroeder; S Vocks; J Kosfelder; B Zernikow; T Hechler
Journal:  Schmerz       Date:  2010-06       Impact factor: 1.107

6.  Pain descriptors of taxane acute pain syndrome (TAPS) in breast cancer patients-a prospective clinical study.

Authors:  Rashi Asthana; Liying Zhang; Bo Angela Wan; Daniela Gallo-Hershberg; Angie Giotis; Mark Pasetka; Jenna van Draanen; Shannon Goodall; Patrick L Diaz; Leah Drost; Edward Chow; Carlo De Angelis
Journal:  Support Care Cancer       Date:  2019-05-17       Impact factor: 3.603

Review 7.  [Current therapy of neuropathic pain].

Authors:  M Schäfers; T R Tölle
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

8.  Diagnosis and assessment of neuropathic pain.

Authors:  Stephen May; Mick Serpell
Journal:  F1000 Med Rep       Date:  2009-10-14

9.  Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?

Authors:  Kai-Uwe Kern; Srinivas Nalamachu; Louis Brasseur; Joanna M Zakrzewska
Journal:  J Pain Res       Date:  2013-04-05       Impact factor: 3.133

Review 10.  Identifying biological markers of activity in human nociceptive pathways to facilitate analgesic drug development.

Authors:  Boris A Chizh; Joel D Greenspan; Kenneth L Casey; Michael I Nemenov; Rolf-Detlef Treede
Journal:  Pain       Date:  2008-10-23       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.